Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell - PubMed (original) (raw)
. 1993 Oct 15;151(8):4221-7.
M Willheim, W R Sperr, A Wilfing, E Krömer, E Kabrna, E Spanblöchl, H Strobl, K Geissler, A Spittler, G Boltz-Nitulescu, O Majdic, K Lechner, P Valent
Affiliations
- PMID: 7691941
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell
H Agis et al. J Immunol. 1993.
Abstract
Mast cells (MC3) belong to the hemopoietic system and arise from hemopoietic precursor cells. Human MC progenitors can be detected in the bone marrow as well as in the peripheral blood (pb) and are responsive to the mast cell growth factor SCF, the ligand of the c-kit tyrosine kinase receptor. However, little is known about the subsets of cells that become committed to and differentiate into mature human MC. In this study, the identity of the circulating MC progenitor, previously felt to be a monocyte (Mo) or basophil (Ba), was investigated. For this purpose, CD14+ pb monocytes, CD17+ pb basophils and CD34+ cord blood cells were purified to homogeneity (> 95%) from mononuclear cells (normal adult donors, n = 17, cord blood, n = 2) by counter-flow centrifugation followed by cell sorting with mAb. In the presence of rhSCF, MC developed in long term suspension culture from pure CD34+ cells but not from pure Mo, pure Ba, or Ly (MC-tryptase levels on day 42: CD14+ Mo: 3.7 +/- 0.8 vs CD17+ Ba: 3.2 +/- 0.5 vs Ly: 2.0 +/- 1.5 vs control: 196.5 +/- 92.5 ng/ml, p < 0.001). Depletion of CD34+ cells from MNC resulted in a loss of MC in long term suspension culture, whereas depletion of either Mo, Ba, or Ly did not. In methyl-cellulose cultures in the presence of rhSCF, MC and tryptase could be detected in pure (CFU-mast) and mixed (CFU-myeloid/mast) MC colonies. Together, MC do not originate from circulating Mo, Ba, or Ly. The circulating MC progenitor is a CD34+, c-kit+, Ly-, CD14-, CD17- colony-forming cell. This is the first definitive demonstration that mast cells are replenished directly from early hemopoietic progenitors and thus form a unique cell lineage within the hemopoietic system.
Similar articles
- Expansion of cord blood progenitors and use for hemopoietic reconstitution.
Gabutti V, Timeus F, Ramenghi U, Crescenzio N, Marranca D, Miniero R, Cornaglia G, Bagnara GP. Gabutti V, et al. Stem Cells. 1993 Jul;11 Suppl 2:105-12. doi: 10.1002/stem.5530110818. Stem Cells. 1993. PMID: 7691315 - c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK. Simmons PJ, et al. Exp Hematol. 1994 Feb;22(2):157-65. Exp Hematol. 1994. PMID: 7507857 - The c-kit proto-oncogene in normal and malignant human hematopoiesis.
Ratajczak MZ, Luger SM, Gewirtz AM. Ratajczak MZ, et al. Int J Cell Cloning. 1992 Jul;10(4):205-14. doi: 10.1002/stem.5530100403. Int J Cell Cloning. 1992. PMID: 1379619 Review. - Human hemopoietic progenitors and their signals.
Messner HA. Messner HA. Bone Marrow Transplant. 1991;7 Suppl 1:18-22. Bone Marrow Transplant. 1991. PMID: 1710522 Review.
Cited by
- Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles.
Jiménez M, Cervantes-García D, Córdova-Dávalos LE, Pérez-Rodríguez MJ, Gonzalez-Espinosa C, Salinas E. Jiménez M, et al. Front Immunol. 2021 Jun 15;12:685865. doi: 10.3389/fimmu.2021.685865. eCollection 2021. Front Immunol. 2021. PMID: 34211473 Free PMC article. Review. - Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
Sprinzl B, Greiner G, Uyanik G, Arock M, Haferlach T, Sperr WR, Valent P, Hoermann G. Sprinzl B, et al. Int J Mol Sci. 2021 Feb 28;22(5):2458. doi: 10.3390/ijms22052458. Int J Mol Sci. 2021. PMID: 33671092 Free PMC article. Review. - Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.
Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Kovanen PT, Hadzijusufovic E, Sadovnik I, Horny HP, Arock M, Schwartz LB, Austen KF, Metcalfe DD, Galli SJ. Valent P, et al. Theranostics. 2020 Aug 29;10(23):10743-10768. doi: 10.7150/thno.46719. eCollection 2020. Theranostics. 2020. PMID: 32929378 Free PMC article. Review. - Identification and Immunophenotypic Characterization of Normal and Pathological Mast Cells.
Morgado JM, Sánchez-Muñoz L, Teodósio C, Mora LME. Morgado JM, et al. Methods Mol Biol. 2020;2163:331-353. doi: 10.1007/978-1-0716-0696-4_27. Methods Mol Biol. 2020. PMID: 32766988 - Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells.
Grootens J, Ungerstedt JS, Nilsson G, Dahlin JS. Grootens J, et al. Blood Adv. 2018 Sep 11;2(17):2273-2281. doi: 10.1182/bloodadvances.2018019539. Blood Adv. 2018. PMID: 30206100 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials